King Charles suffered such side effects from chemotherapy, that he was apparently forced to cancel engagements with three ...

A new study shows that hydroxyurea, an oral drug, safely and effectively manages sickle cell disease in children. Kids who ...

In advanced head and neck squamous cell carcinoma, evorpacept and Keytruda didn’t meet the primary endpoints of the ASPEN-03 ...

MONDAY, April 21, 2025 (HealthDay News) -- An oral chemotherapy drug can safely and effectively manage sickle cell disease in children, a new study says. Children taking hydroxyurea had fewer ER ...

Penpulimab is approved for multiple indications in China, but this marks the first US approval for the novel monoclonal ...

The FDA approved the PD-1 inhibitor penpulimab, with two indications, for treating non-keratinizing nasopharyngeal carcinoma ...

Approval of penpulimab-kcqx marks the company’s US regulatory debut and introduces a new immunotherapy option for advanced ...

Dr. Matthew Galsky highlights the impact of Imfinzi’s adjuvant approval for patients with muscle-invasive bladder cancer ...

An oral chemo drug is safe and effective for sickle cell disease in children Hydroxyurea helps red blood cells retain a healthy, round shape The drug significantly reduced ER visits and hospital ...

“Our results reinforce that hydroxyurea, the most efficacious medicine available for sickle cell disease, continues to have ...